BGPT: Paper Review: Nedd8 modification of Cullin-5 regulates lipopolysaccharide-induced acute lung injury

Fuel Your Discoveries

Quick Explanation Copied

Core claim: the paper proposes that Nedd8 modification of Cullin-5 (Cul-5) is required for Cul-5 to bind and potentiate TRAF6 polyubiquitination, driving NF-κB activation and inflammatory mediator production in an LPS-induced acute lung injury mouse model .

Skeptical note: the evidence chain is coherent, but relies heavily on hemizygous Cul-5 deficiency and on MLN4924 (broad neddylation inhibitor), so part of the phenotype may reflect effects on other neddylated cullins or CRL substrates .

Long Explanation

Paper review (skeptical, evidence-based): Nedd8 modification of Cullin-5 regulates lipopolysaccharide-induced acute lung injury

DOI: 10.1152/ajplung.00410.2016 Date (paper metadata provided): July 1, 2017

Review focus

LPS→TLR4→TRAF6→NF-κB axis
Where Cul-5 and Nedd8 fit mechanistically
Strengths, missing controls, and alternative explanations

Evidence chain schematic (from the paper’s claims)

This is a claims map (not quantitative). It preserves the logical ordering of experiments as described.

Cell-type emphasis in the experimental design

From the paper text provided: in vivo macrophage adoptive transfer + in vitro macrophage-like readouts.

1) What the study sets out to test

The authors frame a mechanistic hypothesis: Cul-5 regulates TLR4-linked inflammation via TRAF6, and Nedd8 modification of Cul-5 is required to enable Cul-5’s functional interaction with TRAF6, culminating in NF-κB activation and inflammatory mediator production during LPS-induced ALI .

2) In vivo findings: Cul-5 deficiency correlates with reduced ALI severity

The in vivo model is intratracheal LPS challenge in age/sex/weight-matched wild-type vs Cul-5 +/- mice. The authors report (at early post-LPS timepoints) that Cul-5 haploinsufficiency attenuates lung pathology scores, neutrophil sequestration/infiltration readouts (MPO activity), vascular barrier disruption (Evans blue albumin extravasation), and BALF cellular/protein accumulation, along with reduced mRNA/protein levels of multiple inflammatory cytokines/chemokines .

Skeptical reading:

Genetic model limitation: the study uses Cul-5 +/- (full knockout is embryonically lethal). That means the strongest possible conclusion is about reduced Cul-5 dosage rather than complete loss-of-function .
Endpoint window: major measurements are described around ~6 hours (for mechanistic readouts and for injury analysis) and ~12–24 hours (for some BALF/histology). The paper text provided does not give a fine-grained time-course across all endpoints .

3) Causality via macrophage adoptive transfer

To test whether the phenotype is macrophage-driven, the authors perform intratracheal adoptive transfer of peritoneal macrophages between histocompatible strains: Cul-5 +/- macrophages are delivered into wild-type recipients, and the LPS phenotype is then assessed. They report that transfer of Cul-5 +/- macrophages attenuates ALI readouts in wild-type mice, including histology, MPO activity, BALF protein/cell counts, and cytokine/chemokine outputs .

Skeptical reading:

Cell type resolution: the paper uses peritoneal macrophages as donor cells, and also studies alveolar macrophages in culture. While they conclude macrophages likely dominate, the provided text indicates multiple lung macrophage subsets exist and the study does not resolve subset-specific Cul-5 function .

4) Neddylation requirement for LPS-driven inflammatory cytokine expression

The authors test whether neddylation is upstream/required by using MLN4924 (an inhibitor of the Nedd8-activating step) in macrophage models (primary macrophages and THP-1-Cul-5 stable cells), and by knocking down Nedd8 with siRNA/shRNA. They report that MLN4924 treatment and Nedd8 knockdown abrogate LPS-induced inflammatory cytokine/chemokine expression and also suppress Cul-5–mediated cytokine production .

Critical alternative explanation:

Broad mechanism concern: MLN4924 inhibits neddylation broadly, not only Cul-5. The authors explicitly note that cytokine inhibition magnitude with MLN4924 exceeds the effect expected from Cul-5 hemizygosity, and they discuss possible off-target/broader CRL pathway contributions (e.g., IκBα/β-TrCP-related impacts) .

5) Mechanism proposed: Cul-5 neddylation enables TRAF6 binding, polyubiquitination, and NF-κB activity

The paper’s mechanistic core uses co-immunoprecipitation and reporter assays in transfected systems to test whether neddylation status changes Cul-5 interaction with TRAF6, TRAF6 dimerization, TRAF6 polyubiquitination, and NF-κB reporter activity. The key mechanistic claims are:

MLN4924 blocks the neddylated band of Cul-5 (neddylation status readout).
MLN4924 reduces Cul-5 binding to TRAF6.
Cul-5 promotes TRAF6 dimerization, and this enhancement is abrogated by MLN4924.
Cul-5-driven TRAF6 polyubiquitination is reduced by MLN4924 or Nedd8 knockdown.
A Cul-5 neddylation site mutant (K724R) reduces the ability of Cul-5 to promote TRAF6 polyubiquitination.
Cul-5 enhances NF-κB luciferase activity, and MLN4924 abrogates it.

These points are all stated directly in the paper’s Results description .

Biological plausibility (outside the paper, mechanistic context): Nedd8 activation is known to structurally activate cullin-RING ligases by conformational control and assembly principles; cryo-EM work provides mechanistic insight into how Nedd8 nucleates multivalent cullin-RING-UBE2D ubiquitin ligation assemblies .

However, the paper’s specific claim (Cul-5 neddylation specifically enables TRAF6 binding and the downstream TRAF6 ubiquitin signal) still depends on the study’s experimental design and controls .

6) Critical appraisal (what looks strong vs what remains uncertain)

Strengths (within what is shown in the provided text)

Multi-level consistency: in vivo ALI phenotype tracks with macrophage transfer experiments and with mechanistic macrophage signaling experiments .
Multiple perturbation strategies: pharmacologic inhibition (MLN4924), Nedd8 knockdown, and a Cul-5 neddylation-site mutant (K724R) converge on the pathway claim .

Uncertainties / blind spots explicitly or implicitly suggested by the text

Non-specificity of MLN4924: the authors themselves discuss that MLN4924 inhibition could reflect effects beyond Cul-5, so causal attribution specifically to Cul-5 neddylation (vs broad CRL inhibition) remains partially uncertain .
In vivo timing and stoichiometry: the provided text does not include quantitative kinetic data on neddylated Cul-5 abundance over time in vivo, so the claim that LPS induces Cul-5 neddylation at the relevant causal window is not numerically constrained .
Species/model generalization: the Discussion states the LPS ALI model does not fully reproduce key aspects of human ARDS, suggesting translation limits .

Claim-confidence matrix (based only on the provided text)

“Strong” here means: multiple described experimental perturbations and readouts within the paper text; “Moderate/Weak” means: limited details in the provided excerpt or explicit non-specificity concerns.

Paper claim (short)	Evidence type(s) in text	Confidence (qualitative)
Cul-5 hemizygosity reduces LPS-ALI injury	Histology, MPO, Evans blue, BALF cytokines/cell/protein, tissue mRNA	Strong
Macrophage Cul-5 causal role	Intratracheal adoptive transfer of macrophages	Strong
Neddylation required for LPS cytokine expression	MLN4924 + Nedd8 knockdown/THP-1-Cul-5	Moderate
Cul-5–TRAF6 binding depends on Nedd8	Co-IP ± MLN4924; neddylation-site mutant (K724R)	Moderate
Cul-5 neddylation drives TRAF6 polyubiquitination & NF-κB	TRAF6 ubiquitination assays; NF-κB luciferase; perturbations	Moderate

Evidence mapping is drawn from the paper excerpt you provided, primarily .

Explore deeper on BGPT (bespoke actions)

Author reviews (BGPT shortcuts)

Feedback:

Updated: March 28, 2026